Skip directly to Accessibility Notice

How to Purchase

Sign-up to Receive
Our Latest Insights

BBH
VanEck Vectors Biotech ETF

Fund Description

VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

 
 

  • Fund Ticker

    BBH
  • Exchange

    NASDAQ
  • Commencement

    12/20/2011
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    Bank of New York Mellon
  • Index Ticker

    MVBBHTR
  • Index Rebalancing

    Quarterly

 
as of 09/17/19

  • 30-Day SEC Yield1

    0.43%
  • Total Net Assets

    $338.4M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.40%
  • Net Expense Ratio/TER2

    0.35%
  • Distribution Frequency

    Annual
  • Next Distribution Date

    12/20/2019

Portfolio Composition (%)
as of 09/17/19

  • % of Net Assets
  • Stocks

    99.95
  • Bonds

    0.00
  • Other

    0.00
  • Cash

    0.05

Daily Holdings (%) as of 09/17/19 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
Amgen Inc
AMGN US
183,199
36,038,907 10.65
Gilead Sciences Inc
GILD US
403,138
26,675,641 7.88
Celgene Corp
CELG US
250,077
24,657,592 7.29
Allergan Plc
AGN US
136,155
22,615,346 6.68
Iqvia Holdings Inc
IQV US
118,997
18,199,401 5.38
Biogen Inc
BIIB US
72,246
17,245,120 5.10
Vertex Pharmaceuticals Inc
VRTX US
97,566
17,171,616 5.07
Incyte Corp
INCY US
197,663
15,635,143 4.62
Illumina Inc
ILMN US
49,087
14,641,179 4.33
Exact Sciences Corp
EXAS US
133,443
14,261,053 4.21
Beigene Ltd
BGNE US
106,670
14,199,910 4.20
Regeneron Pharmaceuticals Inc
REGN US
48,940
14,100,593 4.17
Alexion Pharmaceuticals Inc
ALXN US
124,185
13,390,869 3.96
Biomarin Pharmaceutical Inc
BMRN US
173,268
12,995,100 3.84
Qiagen Nv
QGEN US
335,876
11,463,448 3.39
Neurocrine Biosciences Inc
NBIX US
96,988
9,835,553 2.91
Charles River Laboratories Internationa
CRL US
69,374
9,320,397 2.75
Alnylam Pharmaceuticals Inc
ALNY US
99,042
8,697,868 2.57
Grifols Sa
GRFS US
416,629
8,270,086 2.44
Sarepta Therapeutics Inc
SRPT US
91,448
7,762,106 2.29
Ionis Pharmaceuticals Inc
IONS US
98,504
6,381,089 1.89
Seattle Genetics Inc
SGEN US
73,453
5,284,943 1.56
United Therapeutics Corp
UTHR US
51,535
4,425,310 1.31
Nektar Therapeutics
NKTR US
132,281
2,738,217 0.81
Bluebird Bio Inc
BLUE US
20,917
2,232,262 0.66
Other/Cash
--
--
177,065 0.05
These are not recommendations to buy or to sell any security. Securities and holdings may vary.